emerg
highli
pathogen
variant
strain
porcin
epidem
diarrhea
viru
pedv
led
signific
econom
loss
global
swine
industri
mani
studi
describ
coronavirus
enter
cell
inform
pedv
invas
strategi
remain
insuffici
given
differ
gene
sequenc
pathogen
classic
mutant
strain
pedv
may
lead
divers
invas
mechan
studi
focus
cellular
entri
pathway
cellular
transport
pedv
gi
gii
subtyp
strain
vero
cell
cell
first
character
kinet
pedv
entri
cell
found
highest
invas
rate
pedv
approxim
cell
approxim
vero
cell
clarifi
specif
endocyt
pathway
systemat
research
method
use
show
pedv
enter
cell
via
clathrinand
caveolaemedi
endocytosi
pathway
dynamin
ii
clathrin
heavi
chain
cholesterol
indispens
involv
addit
lipid
raft
extract
assay
show
pedv
also
enter
cell
lipid
raftmedi
endocytosi
investig
traffick
intern
pedv
found
pedv
entri
cell
reli
low
ph
intern
virion
reach
lysosom
earli
endosomel
endosomelysosom
pathway
result
concret
reveal
entri
mechan
pedv
provid
insight
theoret
basi
understand
pedv
pathogenesi
guidanc
new
target
antivir
drug
author
articl
licens
creativ
common
attribut
intern
licens
permit
use
share
adapt
distribut
reproduct
medium
format
long
give
appropri
credit
origin
author
sourc
provid
link
creativ
common
licenc
indic
chang
made
imag
third
parti
materi
articl
includ
articl
creativ
common
licenc
unless
indic
otherwis
credit
line
materi
materi
includ
articl
type
alphacoronaviru
porcin
epidem
diarrhea
viru
pedv
caus
enorm
econom
loss
global
pork
industri
especi
emerg
highli
pathogen
pedv
variant
strain
pedv
first
report
uk
afterward
also
discov
europ
asia
although
pedv
persist
asian
swineproduc
countri
attract
enough
global
attent
octob
sever
ped
outbreak
occur
even
chines
pig
farm
alreadi
vaccin
liveattenu
vaccin
first
pedv
outbreak
occur
us
rapidli
spread
across
entir
countri
molecular
epidemiolog
result
show
genet
differ
classic
gi
subtyp
new
pedv
variant
strain
gii
subtyp
pedv
present
recogn
worldwid
due
dramat
chang
observ
epidem
charact
pathogen
properti
gene
drift
studi
focus
pathogenesi
immun
evas
develop
effect
vaccin
progress
viru
noncellular
life
form
must
reli
cell
complet
life
cycl
first
step
viru
infect
success
entri
cell
envelop
virus
enter
cell
cellular
endocytosi
endocyt
pathway
util
virus
vari
includ
clathrinmedi
endocytosi
cme
caveolaemedi
endocytosi
lipid
raftmedi
endocytosi
macropinocytosi
among
other
cme
classic
wellknown
endocyt
pathway
util
virus
bind
cell
surfac
receptor
viru
packag
clathrinco
pit
ccp
transport
clathrinco
vesicl
ccv
viru
particl
cargo
transport
earli
endosom
caveola
plasmaspecif
invagin
structur
diamet
nm
viral
particl
interact
receptor
caveola
coat
invagin
pinch
plasma
membran
caveola
vesicl
matur
caveosom
deliv
cargo
earli
endosom
lipid
raft
plasma
membran
microdomain
enrich
sphingolipid
cholesterol
particip
later
organ
cell
surfac
raftmedi
endocytosi
process
intern
ligand
receptor
domain
mechan
coronavirus
entri
cell
alreadi
studi
sever
acut
respiratori
syndrom
coronaviru
sarscov
murin
hepat
viru
mhv
human
coronaviru
hcov
entri
sarscov
cell
clathrindepend
entri
vero
cell
clathrinand
caveolaeindepend
lipid
raft
play
import
role
process
mhv
entri
cell
need
clathrin
caveolaemedi
endocytosi
util
enter
human
fibroblast
cell
sarscov
mhvcov
induc
continu
micropinocytosi
occur
later
phase
infect
associ
viru
entri
coronavirus
enter
host
cell
via
variou
endocyt
pathway
viral
spike
glycoprotein
interact
receptor
initi
endocyt
process
intern
virus
traffick
like
cargo
membran
fusion
site
specif
transport
rout
differ
cov
vari
fusion
site
fusion
site
middl
east
respiratori
syndrom
coronaviru
merscov
take
place
earli
endosom
mhv
felin
infecti
periton
viru
fipv
transport
lysosom
fuse
although
mani
studi
invas
mechan
cov
invas
strategi
pedv
yet
fulli
elucid
park
et
al
reveal
pedv
entri
follow
clathrinmedi
endocytosi
depend
low
ph
success
entri
cell
research
one
pedv
strain
studi
vero
cell
presenc
trypsin
chemic
inhibitor
confoc
method
use
reveal
pedv
entri
howev
still
import
question
address
consid
cov
take
advantag
differ
pathway
enter
cell
whether
differ
subtyp
pedv
invad
cell
differ
way
whether
pedv
enter
differ
type
cell
differ
way
remain
determin
concret
clarifi
entri
transport
rout
pedv
use
vero
cell
model
pedv
entri
chose
strain
highli
pathogen
variant
strain
compar
invas
strategi
differ
pedv
subtyp
result
advanc
understand
pathogenesi
immun
evas
pedv
vero
cell
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
gibco
antibiot
uml
penicillin
streptomycin
cell
grown
dmemnutri
mixtur
supplement
fb
antibiot
pedv
strain
use
studi
strain
gi
subtyp
genbank
id
highli
pathogen
variant
strain
gii
subtyp
genbank
id
exogen
trypsin
ad
prolifer
pedv
strain
vero
cell
ml
trypsin
ad
cell
sbti
soy
bean
trypsin
inhibitor
type
sigma
endocyt
inhibitor
use
includ
dynasor
sigmaaldrich
chlorpromazin
cpz
sigmaaldrich
sigmaaldrich
nystatin
sigmaaldrich
ammonium
chlorid
sigmaaldrich
bafilomycin
baf
sigmaaldrich
antibodi
clathrin
heavi
chain
caveolin
coupl
secondari
goat
antirabbit
alexa
fluor
goat
antimous
alexa
fluor
purchas
abcam
mous
antipedv
monoclon
antibodi
antipedvn
polyclon
antibodi
prepar
laboratori
use
immunofluoresc
analysi
western
blot
analysi
respect
overexpress
plasmid
wildtyp
mutant
dynamin
ii
gfpdynwt
gfpdynm
ep
gfpcavwt
gfpcavm
provid
prof
mark
mcniven
mayo
center
biomed
discoveri
rochest
mn
usa
investig
trypsin
depend
pedv
strain
vero
cell
seed
plate
confluenc
wash
pb
cell
infect
pedv
strain
multipl
infect
moi
without
trypsin
trypsin
sbti
h
quantif
virus
qrtpcr
test
dynam
pedv
intern
vero
cell
seed
plate
confluenc
cell
prechil
min
inocul
pedv
moi
h
viru
bind
cell
wash
three
time
icecold
pb
remov
unbound
virus
immedi
warm
initi
intern
incub
indic
time
interv
cell
treat
proteinas
k
mgml
min
wash
pb
inactiv
remov
nonintern
pedv
particl
control
cell
wash
pb
cell
collect
subject
qrtpcr
analysi
test
effect
inhibitor
pedv
intern
necessari
evalu
cytotox
cell
inhibitor
cell
seed
plate
densiti
cellwel
grown
h
treat
endocyt
inhibitor
indic
concentr
h
solut
ad
well
incub
h
absorb
nm
measur
experi
repeat
three
time
independ
concentr
use
inhibitor
caus
signific
cytotox
cell
viabil
test
effect
inhibitor
pedv
intern
cell
pretreat
differ
concentr
drug
h
infect
strain
moi
presenc
drug
h
wash
citrat
buffer
ph
pb
cell
incub
medium
contain
trypsin
h
h
collect
qrtpcr
western
blot
analysi
respect
express
pedv
n
protein
detect
qrtpcr
western
blot
gapdh
refer
total
rna
extract
use
trizol
invitrogen
accord
manufactur
instruct
cdna
synthes
revertra
ace
qpcr
rt
master
mix
gdna
remov
kit
toyobo
osaka
japan
qpcr
reaction
perform
use
sybr
premix
ex
taq
ii
kit
takara
tokyo
japan
use
light
cycler
realtim
pcr
system
roch
diagnost
indianapoli
usa
western
blot
analysi
cell
wash
pb
lyse
ripa
lysi
buffer
ice
min
sdspage
electrophoresi
protein
transfer
onto
polyvinyliden
fluorid
pvdf
membran
via
semidri
method
immunoblot
correspond
antibodi
transfect
vero
cell
cell
overexpress
plasmid
wildtyp
mutant
dynamin
ii
gfpdynwt
gfpdynm
ep
gfpcavwt
gfpcavm
perform
use
lipofectamin
invitrogen
transfect
reagent
accord
manufactur
protocol
cell
seed
plate
confluenc
h
transfect
cell
infect
pedv
moi
h
viru
move
citrat
buffer
pb
replac
fresh
medium
contain
trypsin
viru
intern
evalu
confoc
fluoresc
microscop
rna
interfer
assay
sirna
dynamin
ii
sidyn
su
scrofa
ctc
atg
atc
aat
aac
chlorocebu
sabaeu
aca
tca
aca
cga
acc
clathrin
heavi
chain
sichc
su
scrofa
ata
cca
tga
ctg
atg
chlorocebu
sabaeu
gaa
cct
tat
gca
tgc
ep
su
scrofa
gtg
gat
att
ctt
gga
chlorocebu
sabaeu
aga
aac
agc
aag
tac
sicav
su
scrofa
cat
gca
gaa
aga
aat
chlorocebu
sabaeu
tca
ctg
tga
cga
agt
design
synthes
base
correspond
fulllength
mrna
sequenc
su
scrofa
chlorocebu
sabaeu
sirna
ggt
gga
tga
cag
act
tca
aga
gag
act
act
design
synthes
base
correspond
mrna
homolog
sequenc
su
scrofa
chlorocebu
sabaeu
control
sirna
sicontrol
design
synthes
irrelevantli
known
gene
su
scrofa
chlorocebu
sabaeu
genom
respect
ribobio
guangzhou
china
cell
seed
plate
confluenc
ensur
transfect
effici
second
transfect
carri
h
first
transfect
h
postfirst
transfect
cell
infect
pedv
moi
h
viru
move
citrat
buffer
pb
replac
fresh
medium
contain
trypsin
viru
intern
evalu
qrtpcr
western
blot
hpi
hpi
respect
label
transferrin
trf
label
cholera
toxin
b
subunit
ctb
dilut
mix
pedv
moi
cell
wash
three
time
pb
ad
mixtur
pedv
trf
ctb
h
incub
min
intern
wash
pb
cell
fix
permeabil
block
incub
mous
antipedv
monoclon
antibodi
incub
alexa
goat
antimous
igg
h
l
stain
dapi
analyz
use
confoc
fluoresc
microscop
light
exposur
avoid
throughout
experi
cell
cultur
glassbottom
dish
h
wash
icecold
pb
incub
pedv
h
cold
virus
replac
prewarm
medium
cell
immedi
shift
specif
time
point
cell
fix
paraformaldehyd
rt
min
wash
three
time
pb
permeabil
carri
triton
rt
min
wash
pb
cell
block
bsa
pbst
rt
min
block
unspecif
bind
site
specif
primari
antibodi
chc
antipedv
antibodi
use
probe
cell
overnight
cell
incub
secondari
antibodi
goat
antirabbit
igg
antibodi
conjug
alexa
fluor
goat
antimous
igg
antibodi
conjug
alexa
fluor
h
fluoresc
imag
acquir
use
lightscan
modul
leica
tc
sted
confoc
microscop
cell
incub
incub
pedv
h
wash
three
time
icecold
pb
lyse
ml
tne
buffer
mm
tri
mm
nacl
mm
edta
ph
contain
triton
phenylmethanesulfonyl
fluorid
pmsf
ice
min
homogen
cell
lysat
centrifug
min
g
supernat
mix
isometr
ml
contain
sucros
tne
buffer
lysatessucros
mixtur
place
bottom
ultracentrifug
tube
overlaid
ml
ml
sucros
tne
buffer
cell
lysat
ultracentrifug
h
g
rotor
beckman
centrifug
twelv
ml
fraction
collect
top
bottom
tube
fraction
concentr
peg
overnight
pellet
resuspend
tne
buffer
centrifug
min
g
local
lipid
raftassoci
protein
pedv
n
protein
analyz
western
blot
graph
creat
graphpad
prism
softwar
data
present
mean
standard
deviat
sd
least
three
independ
experi
signific
estim
use
oneway
anova
multipl
comparison
control
p
valu
less
defin
threshold
statist
signific
p
valu
mark
one
asterisk
p
valu
mark
two
asterisk
p
valu
mark
three
asterisk
p
valu
less
mark
four
asterisk
coronaviru
entri
inextric
link
proteolyt
process
protein
case
pedv
trypsin
depend
thu
investig
trypsin
depend
strain
use
research
shown
figur
strain
need
trypsin
strain
trypsin
independ
ad
trypsin
follow
assay
explor
invas
mechan
pedv
dynam
virus
invad
differ
kind
cell
vari
may
differ
among
variou
subtyp
viru
thu
necessari
know
entri
dynam
pedv
studi
endocyt
pathway
cell
incub
pedv
moi
adsorpt
shift
initi
intern
adsorb
intern
virion
remov
proteinas
k
pedv
invas
rate
differ
time
point
detect
use
qrtpcr
invas
kinet
figur
show
pedv
particl
detach
cell
proteinas
k
begin
invas
min
vero
cell
figur
min
cell
figur
nearli
maximum
proport
viral
particl
complet
intern
approxim
pedv
particl
enter
vero
cell
enter
cell
notabl
strain
demonstr
less
effici
invas
strain
signific
differ
dynamin
ii
play
essenti
role
cellular
membran
fusion
vesicl
format
due
gtpase
activ
necessari
clathrinand
caveolaemedi
endocytosi
thu
explor
essenti
dynamin
ii
pedv
entri
use
specif
chemic
inhibitor
overexpress
domainneg
mutant
dynamin
ii
sirna
interfer
dynasor
cellperm
noncompetit
inhibitor
dynamin
ii
use
pretreat
cell
differ
concentr
analyz
effect
pedv
entri
cytotox
test
show
dynasor
effect
viabil
vero
cell
addit
file
cell
pretreat
dynasor
h
pedv
infect
dmso
use
neg
control
effect
dynasor
pedv
entri
quantifi
qrtpcr
hpi
pedv
invas
significantli
inhibit
dynasor
concentr
invas
rate
strain
vero
cell
approxim
invas
rate
cell
respect
figur
comparison
invas
rate
strain
indic
strain
sensit
dynasor
strain
invad
cell
signific
differ
invad
vero
cell
mani
studi
use
overexpress
domin
neg
mutant
explor
role
dynamin
ii
viru
entri
mutat
dynamin
ii
inhibit
gtpase
activ
reduc
endocytosi
cell
transfect
wildtyp
mutant
type
dynamin
ii
respect
infect
strain
h
transfect
confoc
result
show
vero
cell
overexpress
wildtyp
dynamin
ii
gfpdynwt
infect
pedv
cell
overexpress
mutant
dynamin
ii
gfpdynm
bare
infect
figur
sirna
interfer
also
use
identifi
import
dynamin
ii
viru
entri
su
scrofa
chlorocebu
sabaeu
sirna
dynamin
ii
sidyn
design
synthes
interfer
effici
sirna
dynamin
ii
express
vero
cell
obviou
mrna
protein
level
addit
file
cell
infect
pedv
transfect
twice
intern
virion
quantifi
hpi
hpi
qrtpcr
western
blot
assay
respect
qrtpcr
result
figur
show
knockdown
dynamin
ii
express
reduc
pedv
intern
intern
rate
strain
vero
cell
approxim
intern
rate
cell
approxim
respect
signific
differ
strain
two
cell
figur
result
confirm
western
blot
figur
taken
togeth
result
suggest
pedv
entri
reli
dynamin
ii
clathrinmedi
endocytosi
commonli
use
classic
endocyt
pathway
viru
entri
identifi
whether
pedv
util
cme
enter
cell
coinocul
vero
cell
pedv
trf
typic
biomolecul
use
cme
enter
cell
coinocul
result
figur
trypsindepend
kinet
pedv
entri
cell
vero
cell
seed
plate
confluenc
cell
wash
pb
infect
pedv
strain
moi
without
trypsin
presenc
trypsin
trypsin
sbti
cell
collect
qrtpcr
hpi
b
c
vero
cell
b
cell
c
incub
pedv
strain
respect
h
shift
immedi
initi
intern
min
incub
cell
treat
proteinas
k
mgml
min
inactiv
nonintern
virion
control
cell
wash
pb
invas
rate
calcul
qrtpcr
analysi
p
dynamin
ii
involv
pedv
entri
cell
pretreat
dynasor
h
respect
incub
strain
h
dmso
use
neg
control
cell
collect
hpi
qrtpcr
assay
test
invas
effici
pedv
b
vero
cell
transfect
gfpdynwt
gfpdynm
respect
infect
pedv
strain
h
transfect
cell
fix
hpi
stain
confoc
analysi
c
vero
cell
transfect
sidyn
twice
infect
pedv
strain
h
second
transfect
invas
rate
pedv
cell
detect
hpi
hpi
qrtpcr
western
blot
analysi
respect
ctrl
mean
control
scale
bar
indic
p
p
p
show
pedv
coloc
trf
two
type
cell
figur
mean
pedv
might
util
clathrinmedi
endocytosi
enter
cell
prove
conjectur
use
specif
chemic
inhibit
overexpress
domain
neg
mutant
ep
knockdown
express
chc
ep
sirna
locat
pedv
cell
estim
role
clathrinmedi
endocytosi
pedv
entri
cpz
specif
chemic
inhibitor
use
block
cme
pathway
prevent
assembl
ccp
plasma
membran
cytotox
test
show
cpz
effect
viabil
vero
cell
cpz
effect
viabil
cell
addit
file
vero
cell
treat
cpz
differ
concentr
h
infect
pedv
intern
rate
pedv
cpz
treatment
quantifi
qrtpcr
western
blot
hpi
hpi
respect
qrtpcr
result
figur
show
pedv
invas
significantli
inhibit
cpz
invas
rate
strain
highest
drug
concentr
nearli
vero
cell
cell
respect
notabl
signific
differ
strain
vero
cell
strain
sensit
strain
cell
reflect
strain
significantli
decreas
invas
rate
figur
result
also
observ
western
blot
figur
ifa
assay
addit
file
role
cme
endocytosi
also
identifi
overexpress
gfptag
domin
neg
mutant
ep
ep
critic
compon
ccp
interact
adaptor
protein
major
clathrin
adaptor
complex
cell
transfect
wildtyp
mutant
ep
infect
pedv
strain
h
transfect
confoc
result
pedv
invas
show
cell
overexpress
wildtyp
ep
infect
pedv
infect
observ
overexpress
cell
figur
sirna
also
use
explor
role
cme
pedv
entri
interf
express
clathrin
heavi
chain
chc
ep
chc
clathrin
light
chain
form
triskelion
shape
key
compon
regul
format
disassembl
clathrin
lattic
cell
infect
pedv
strain
transfect
twice
invas
rate
virus
assess
use
qrtpcr
western
blot
assay
hpi
hpi
respect
quantit
experi
show
knockdown
express
chc
significantli
reduc
invas
rate
pedv
invas
rate
strain
vero
cell
cell
respect
signific
differ
strain
figur
knockdown
express
ep
also
significantli
reduc
invas
rate
pedv
invas
rate
strain
vero
cell
cell
respect
signific
differ
strain
figur
signific
inhibit
sichc
pedv
entri
also
observ
western
blot
assay
figur
h
estim
whether
pedv
directli
enter
cell
cme
analyz
local
pedv
chc
vero
cell
respect
precool
cell
incub
pedv
h
adsorpt
shift
intern
five
min
later
cell
wash
fix
observ
use
ultrahighresolut
laser
confoc
microscop
confoc
result
show
pedv
particl
coloc
chc
protein
vero
cell
figur
virion
coloc
chc
result
indic
pedv
enter
cell
cme
pathway
cme
may
pathway
util
pedv
cholesterol
import
compon
cell
membran
emb
phospholipid
bilay
play
crucial
role
fluiditi
cell
membran
mani
studi
show
envelop
viru
reli
cholesterol
invad
cell
viru
invad
cell
depend
presenc
cholesterol
sensit
cholesterol
extract
elimin
cholesterol
plasma
membran
cell
nystatin
bind
cholesterolenrich
region
cell
membran
decompos
cholesterol
impair
cholesterol
synthesi
cytotox
test
show
maximum
toler
concentr
vero
cell
mm
mm
respect
maximum
toler
concentr
nystatin
respect
addit
file
cell
pretreat
differ
concentr
nystatin
h
infect
pedv
effect
drug
pedv
entri
estim
qrtpcr
western
blot
hpi
hpi
respect
show
signific
inhibit
pedv
entri
intern
rate
strain
treatment
approxim
vero
cell
approxim
cell
signific
differ
strain
vero
figur
pedv
entri
reli
cme
pathway
vero
cell
cell
incub
mixtur
label
trf
red
pedv
green
h
shift
min
cell
fix
stain
pedv
use
monoclon
antibodi
pedv
protein
cellular
local
trf
pedv
observ
confoc
fluoresc
microscop
light
exposur
avoid
throughout
process
b
c
vero
cell
pretreat
cpz
cell
pretreat
cpz
respect
h
incub
strain
h
doubledistil
water
use
neg
control
cell
collect
hpi
hpi
qrtpcr
western
blot
assay
respect
test
invas
effici
pedv
vero
cell
left
cell
right
transfect
respect
infect
pedv
strain
h
transfect
cell
fix
hpi
stain
confoc
analysi
eh
vero
cell
cell
transfect
sichc
siep
infect
pedv
strain
h
second
transfect
cell
collect
hpi
hpi
qrtpcr
western
blot
analysi
respect
cell
precool
min
incub
pedv
strain
h
shift
min
initi
intern
wash
three
time
remov
unintern
viral
particl
cell
fix
stain
antipedv
red
antichc
green
primari
antibodi
ctrl
mean
control
scale
bar
indic
p
p
p
cell
cell
strain
sensit
figur
result
confirm
western
blot
figur
ifa
assay
addit
file
pedv
entri
significantli
inhibit
nystatin
treatment
intern
rate
strain
nystatin
treatment
approxim
vero
cell
approxim
cell
strain
sensit
nystatin
strain
vero
cell
figur
result
confirm
western
blot
figur
ifa
assay
addit
file
evalu
import
cholesterol
cell
pretreat
supplement
exogen
cholesterol
infect
pedv
chang
viral
invas
rate
quantifi
qrtpcr
hpi
result
show
ad
exogen
cholesterol
could
significantli
increas
invas
rate
pedv
averag
invas
rate
strain
increas
vero
cell
approxim
cell
figur
result
indic
pedv
invad
enter
cell
depend
cholesterol
two
pedv
subtyp
show
differ
degre
depend
cholesterol
enter
vero
cell
caveola
lipid
raft
rich
cholesterol
sensit
cholesterol
inhibitor
identifi
whether
caveolaemedi
endocytosi
involv
pedv
entri
cell
coinocul
pedv
ctb
enter
cell
interact
specif
receptor
local
result
show
pedv
coloc
ctb
vero
cell
figur
mean
pedv
may
util
caveolaemedi
endocytosi
enter
cell
caveola
mainli
coat
knock
express
separ
interact
factor
block
caveolaemedi
endocyt
pathway
overexpress
domainneg
mutant
block
interact
interact
factor
cell
transfect
wildtyp
gfpcavwt
mutant
gfpcavm
infect
pedv
h
transfect
fix
confoc
observ
hpi
result
show
pedv
infect
gfpcavwtoverexpress
cell
bare
infect
gfpcavmoverexpress
vero
cell
figur
sirna
sicav
design
synthet
knockdown
express
cell
transfect
sicav
twice
infect
pedv
second
transfect
invas
rate
pedv
measur
qrtpcr
western
blot
hpi
hpi
respect
qrtpcr
result
show
knockdown
express
reduc
intern
pedv
inhibit
rate
strain
vero
cell
cell
respect
figur
compar
strain
strain
show
higher
degre
reduct
invas
rate
vero
cell
signific
differ
cell
figur
result
confirm
western
blot
assay
figur
identifi
role
caveola
pedv
entri
investig
cellular
local
pedv
precool
cell
incub
pedv
shift
intern
cell
wash
fix
min
observ
ultrahighresolut
laser
confoc
microscop
cellular
local
result
show
pedv
coloc
vero
cell
figur
pedv
enter
cell
caveolaemedi
pathway
pedv
enter
cell
lipid
raft
pathway
viral
compon
contain
lipid
raft
enrich
layer
isol
sucros
densiti
gradient
centrifug
incub
pedv
cell
lyse
subject
sucros
gradient
centrifug
product
extract
top
total
fraction
obtain
western
blot
analysi
use
protein
marker
repres
lipid
raft
layer
result
show
pedv
could
detect
upper
lipid
raft
enrich
layer
almost
virion
concentr
lipid
raft
enrich
layer
vero
cell
figur
virion
detect
upper
lower
compon
cell
figur
differ
strain
proport
virion
upper
lower
compon
cell
particl
mainli
present
upper
layer
amount
particl
present
lower
layer
figur
result
indic
pedv
util
lipid
raft
enter
cell
virus
enter
cell
via
endocytosi
usual
traffick
endocyt
vesicl
earli
endosom
sort
transport
late
endosom
fuse
earli
endosom
virus
fuse
earli
endosom
releas
genom
cytoplasm
enter
late
endosom
acidif
matur
earli
endosom
similarli
figur
pedv
entri
reli
cholesterol
b
vero
cell
cell
pretreat
mm
mm
mm
mm
respect
h
incub
strain
h
doubledistil
water
use
neg
control
cell
collect
hpi
hpi
qrtpcr
western
blot
assay
respect
test
invas
effici
pedv
c
vero
cell
cell
pretreat
nystatin
respect
h
incub
strain
h
dmso
use
neg
control
cell
collect
hpi
hpi
qrtpcr
western
blot
assay
respect
test
invas
effici
pedv
e
vero
cell
cell
pretreat
differ
concentr
h
supplement
solubl
cholesterol
h
infect
pedv
strain
h
cell
collect
hpi
qrtpcr
assay
test
invas
effici
pedv
p
p
p
p
vero
cell
cell
incub
mixtur
label
ctb
red
pedv
green
h
shift
min
cell
fix
stain
pedv
use
monoclon
antibodi
protein
cellular
local
ctb
pedv
observ
confoc
fluoresc
microscop
light
exposur
avoid
throughout
process
b
vero
cell
cell
transfect
wildtyp
gfpcavwt
domain
neg
mutant
gfpcavm
respect
infect
pedv
strain
h
transfect
cell
fix
hpi
stain
confoc
analysi
c
vero
cell
cell
transfect
sicav
twice
infect
pedv
strain
h
second
transfect
cell
collect
hpi
hpi
qrtpcr
western
blot
analysi
respect
ctrl
mean
control
e
cell
precool
min
incub
pedv
strain
h
shift
initi
intern
min
wash
three
time
remov
viral
particl
intern
cell
fix
stain
antipedv
red
green
primari
antibodi
scale
bar
indic
b
e
p
p
p
p
ph
environ
late
endosom
meet
requir
conform
chang
viral
glycoprotein
caus
membran
fusion
virus
enter
lysosom
transport
late
endosom
final
achiev
membran
fusion
virus
requir
acid
ph
traffic
endosom
therefor
necessari
clarifi
whether
pedv
reli
low
ph
environ
inhibitor
endosom
acidif
baf
vatpas
inhibitor
block
traffic
endocyt
cargo
earli
endosom
late
endosom
inhibit
stabil
low
ph
environ
lysosom
lumen
cell
pretreat
differ
concentr
baf
addit
file
infect
pedv
addit
file
invas
rate
pedv
measur
qrtpcr
western
blot
hpi
hpi
respect
result
show
cell
pretreat
significantli
inhibit
pedv
entri
invas
rate
strain
approxim
vero
cell
cell
figur
signific
inhibit
also
confirm
western
blot
figur
ifa
assay
addit
file
baf
significantli
inhibit
pedv
entri
invas
rate
strain
approxim
vero
cell
cell
figur
western
blot
figur
ifa
assay
addit
file
also
confirm
inhibit
baf
result
prove
pedv
entri
requir
low
ph
earli
endosom
matur
late
endosom
increas
intralumin
acid
proton
pump
activ
late
endosom
becom
larger
vesicl
fuse
type
endosom
mostli
exist
form
multivesicular
bodi
mvb
late
endosom
releas
incorpor
prepar
fuse
lysosom
explor
whether
pedv
particl
traffick
intern
interf
express
involv
late
endosom
involv
late
endosometolysosom
matur
identifi
whether
viral
particl
coloc
earli
endosom
late
endosom
lysosom
knockdown
express
significantli
inhibit
invas
effici
pedv
invas
rate
strain
vero
cell
cell
figur
similarli
knockdown
express
also
significantli
inhibit
invas
effici
pedv
invas
rate
strain
vero
cell
cell
figur
cellular
locat
pedv
observ
precool
cell
incub
pedv
shift
intern
cell
wash
fix
differ
time
point
shift
observ
use
ultrahighresolut
laser
confoc
microscop
cellular
local
assay
show
intern
pedv
could
coloc
earli
endosom
protein
marker
vero
incub
pedv
h
lyse
tne
buffer
contain
triton
pmsf
ice
min
mix
isometr
sucros
homogen
cell
lysat
subject
ultracentrifug
overlaid
sucros
centrifug
total
fraction
collect
top
bottom
tube
local
lipid
raftassoci
protein
pedv
n
protein
analyz
western
blot
concentr
cell
min
endocytosi
figur
could
coloc
late
endosom
protein
marker
min
endocytosi
figur
late
endosom
mostli
form
mvb
coloc
pedv
lysosom
associ
membran
protein
import
lysosom
membran
compon
also
observ
min
endocytosi
two
type
cell
figur
result
demonstr
pedv
traffick
lysosom
enter
cell
endocytosi
differ
two
pedv
genotyp
cell
sinc
highli
pathogen
variant
strain
emerg
pedv
attract
global
attent
mani
studi
report
vaccin
base
strain
low
protect
effici
reemerg
variant
strain
genotyp
show
pedv
strain
sort
two
genotyp
gi
subtyp
classic
gii
subtyp
variant
nucleotid
sequenc
subunit
protein
similar
gi
gii
show
high
variabl
main
antigen
pedv
protein
incub
strain
h
doubledistil
water
use
neg
control
cell
collect
hpi
hpi
qrtpcr
western
blot
assay
respect
test
invas
effici
pedv
c
vero
cell
cell
pretreat
nm
nm
baf
h
incub
strain
h
dmso
use
neg
control
cell
collect
hpi
hpi
qrtpcr
western
blot
assay
respect
test
invas
effici
pedv
p
p
p
vero
cell
cell
transfect
twice
respect
infect
pedv
strain
h
second
transfect
cell
collect
hpi
qrtpcr
analysi
ctrl
mean
control
ce
vero
cell
cell
precool
min
incub
pedv
strain
h
shift
initi
intern
nonintern
viral
particl
remov
wash
min
shift
cell
fix
stain
antipedv
red
green
primari
antibodi
c
min
shift
cell
fix
stain
antipedv
red
green
primari
antibodi
min
shift
cell
fix
stain
antipedv
red
green
primari
antibodi
e
scale
bar
indic
ce
p
p
p
p
play
import
role
induc
immun
respons
viral
entri
mutat
gene
may
lead
differ
mechan
viru
invas
may
help
elucid
pathogenesi
immun
evas
pedv
sarscov
util
vari
endocyt
rout
invad
differ
cell
wonder
whether
pedv
enter
cell
differ
pathway
burkard
et
al
clarifi
coronaviru
enter
cell
endosomelysosom
pathway
proteolyt
depend
furin
cleavag
site
upstream
fusion
peptid
fp
protein
key
determin
fusion
site
viral
membran
protein
pedv
furin
cleavag
site
conserv
arginin
upstream
put
fp
potenti
cleavag
site
cleav
trypsin
whether
theori
mention
applic
pedv
thu
need
studi
explor
gi
gii
subtyp
pathway
pedv
entri
vero
cell
respect
transport
rout
intern
result
show
two
subtyp
pedv
util
clathrin
caveola
lipid
raftmedi
endocytosi
enter
vero
cell
util
effici
endocyt
pathway
vari
depend
differ
genotyp
type
cell
describ
dynam
curv
pedv
entri
appropri
viral
scaveng
extrem
import
remov
viru
particl
effect
adsorb
cell
surfac
compar
effect
citrat
buffer
ph
proteinas
k
mgml
latter
exhibit
stronger
capac
remov
virus
result
dynam
invas
show
viru
invad
vero
cell
within
min
invas
effici
cell
approxim
although
cell
consid
host
cell
pedv
cell
line
cultur
vitro
lost
polar
growth
state
vivo
possibl
affect
viral
recognit
reduc
infect
effici
viru
show
lower
invas
rate
signific
differ
dynamin
ii
gtpase
play
import
role
endocytosi
pinch
endocyt
vesicl
plasma
necessari
clathrinand
caveolaemedi
endocytosi
found
pedv
entri
dynamin
iidepend
although
sensit
strain
dynasor
vari
consid
low
specif
chemistri
inhibitor
domin
neg
mutant
sirnamedi
knockdown
dynamin
ii
carri
evalu
dynamin
ii
pedv
infect
strain
inhibit
sidynamin
ii
signific
differ
clathrinmedi
endocytosi
classic
commonli
use
pathway
envelop
virus
mani
coronavirus
use
cme
enter
cell
sarscov
entri
cell
cell
phev
entri
cell
ascertain
whether
pedv
util
cme
enter
cell
chemistri
inhibitor
cpz
use
prevent
clathrin
assembl
block
cme
clathrin
compos
light
chain
clc
heavi
chain
chc
form
clathrin
lattic
interact
ep
cpz
pretreat
sirnamedi
knockdown
chc
ep
significantli
reduc
invas
rate
pedv
cell
signific
differ
strain
domin
neg
mutant
provid
specif
method
studi
endocyt
pathway
separ
prototyp
protein
interact
regulatori
factor
studi
also
show
cell
overexpress
domin
neg
mutant
ep
bare
infect
pedv
cell
overexpress
wildtyp
ep
infect
normal
howev
inhibit
endocytosi
overexpress
domin
neg
mutant
may
compens
clathrinindepend
endocyt
pathway
virus
enter
cell
cme
carri
clathrinco
vesicl
coloc
viral
particl
chc
indic
pedv
entri
reli
cme
although
caveola
lipid
raft
compon
cholesterol
two
complet
differ
endocyt
pathway
investig
whether
pedv
use
two
pathway
enter
cell
first
examin
whether
pedv
invas
depend
cholesterol
cholesterol
inhibitor
nystatin
signific
inhibitori
effect
pedv
entri
nystatin
higher
inhibitori
effect
entri
inhibitori
effect
vero
cell
similar
strain
effect
lower
cell
hypothes
cell
invas
mainli
depend
cholesterol
cell
surfac
depend
presenc
cholesterol
cell
surfac
cholesterol
synthesi
exogen
cholesterol
supplement
also
confirm
import
cholesterol
pedv
entri
endocyt
vesicl
form
caveolaemedi
pathway
coat
play
critic
role
process
domin
neg
mutant
rna
interfer
cellular
coloc
viral
particl
provid
evid
pedv
entri
need
collect
subtyp
pedv
enter
vero
cell
caveolaemedi
endocytosi
howev
park
et
al
show
pedv
entri
independ
caveolaeco
pit
assembl
treat
vero
cell
nystatin
differ
result
may
explain
differ
oper
detail
firstli
nystatin
use
incub
pedv
studi
incub
research
park
et
al
concentr
nystatin
use
two
studi
differ
highest
concentr
nystatin
use
park
research
highest
concentr
use
vero
cell
concentr
nystatin
inhibit
entri
pedv
consist
park
result
secondli
park
et
al
ad
methyl
cellulos
block
secondcycl
infect
ad
noth
except
trypsin
medium
whether
reason
caus
two
differ
result
need
studi
lipid
raft
act
platform
cell
signal
transduct
viral
invas
distribut
island
form
plasma
membran
cell
isol
sucros
densiti
gradient
centrifug
western
blot
analysi
show
pedv
n
protein
locat
lipid
raft
upper
layer
cell
shown
figur
pedv
n
protein
also
present
bottom
layer
infect
cell
may
due
differ
composit
plasma
membran
two
kind
cell
demonstr
pedv
gi
subtyp
gii
subtyp
strain
could
enter
vero
cell
via
clathrin
caveola
lipid
raftmedi
endocytosi
pathway
furthermor
also
found
invas
effici
two
strain
differ
differ
endocytosi
pathway
differ
strain
may
due
differ
gene
especi
region
gene
homolog
respons
cell
entri
membran
fusion
bind
receptor
differ
gene
may
lead
differ
bind
abil
affin
protein
receptor
thu
lead
differ
util
initi
effici
differ
endocytosi
pathway
howev
whether
differ
gene
sequenc
caus
differ
invas
effici
strain
need
studi
intern
viral
particl
transport
specif
endosom
membran
fusion
classic
transit
rout
endolysosom
pathway
endocyt
cargo
transport
along
endocyt
vesicl
earli
endosom
late
endosomeslysosom
park
et
al
confirm
nh
cl
could
inhibit
pedv
entri
consist
result
need
confirm
differ
method
studi
addit
chemic
inhibitor
also
use
sirna
interfer
cellular
local
viru
particl
identifi
role
ph
endosom
result
studi
reveal
pedv
entri
reli
low
ph
mean
intern
pedv
particl
transport
endosom
lysosom
demonstr
coloc
viral
particl
liu
et
al
report
pedv
protein
activ
lysosom
cystein
proteas
activ
pedv
entri
howev
base
data
could
conclud
membran
fusion
occur
lysosom
technic
method
necessari
demonstr
mechan
conclus
studi
intern
intracellular
traffick
mechan
pedv
import
understand
viral
pathogenesi
benefit
develop
futur
therapi
strategi
studi
demonstr
gi
gii
subtyp
pedv
enter
vero
cell
via
clathrin
caveola
lipid
raftmedi
endocytosi
pathway
effici
endocytosi
pathway
vari
depend
differ
genotyp
type
cell
intern
pedv
enter
lysosom
earli
late
endosom
result
studi
provid
theoret
basi
understand
pedv
pathogenesi
find
new
target
antivir
drug
